Bi Xiuqiong, Gatanaga Hiroyuki, Tanaka Mari, Honda Miwako, Ida Setsuko, Kimura Satoshi, Oka Shinichi
AIDS Clinical Center, International Medical Center of Japan, Tokyo, Japan.
J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):1-4. doi: 10.1097/00126334-200501010-00001.
The Dynabeads method showed the potential for enumerating CD4 T lymphocytes (CD4 count) in HIV-1-infected individuals. The large volume of Dynabeads required for 1 sample and complex procedure made the method expensive and not easy for use, however. To decrease the cost and simplify the procedure, we reduced the volume of the Dynabeads, added wash times, and skipped over the staining step so as to count the CD4 cells directly under an optical microscope. The CD4 count of 246 blood samples using our modified Dynabeads method (DynabeadsCD4) showed a significant correlation with that obtained by flow cytometry (FlowcytoCD4) (r = 0.91 [P < 0.0001]; slope = 1.03, intercept = -16). The sensitivity and specificity for a CD4 count less than 200 cells/microL were 79% and 94%, and for a CD4 count less than 350 cells/microL, the sensitivity and specificity were 95% and 88%, respectively. The positive and negative predictive values for a CD4 count less than 350 cells/microL were 97% and 83%, respectively. The systematic error was 8 cells/microL (95% confidence interval [CI]: 0.4-16). The cost of Dynabeads for 1 sample was less than $1.00; thus, the estimated cost per DynabeadsCD4 test is less than $3.00, including the cost of other disposable materials. Our modified method is simple, economic, and accurate enough to monitor antiretroviral therapy in resource-limited situations.
Dynabeads方法显示了在HIV-1感染个体中计数CD4 T淋巴细胞(CD4计数)的潜力。然而,每个样本所需的大量Dynabeads以及复杂的操作程序使得该方法成本高昂且使用不便。为了降低成本并简化程序,我们减少了Dynabeads的用量,增加了洗涤次数,并跳过了染色步骤,以便直接在光学显微镜下计数CD4细胞。使用我们改良的Dynabeads方法(DynabeadsCD4)对246份血样进行的CD4计数与通过流式细胞术(FlowcytoCD4)获得的结果显示出显著相关性(r = 0.91 [P < 0.0001];斜率 = 1.03,截距 = -16)。对于CD4计数低于200个细胞/微升,敏感性和特异性分别为79%和94%;对于CD4计数低于350个细胞/微升,敏感性和特异性分别为95%和88%。对于CD4计数低于350个细胞/微升,阳性和阴性预测值分别为97%和83%。系统误差为8个细胞/微升(95%置信区间[CI]:0.4 - 16)。每个样本的Dynabeads成本低于1.00美元;因此,估计每次DynabeadsCD4检测的成本低于3.00美元,包括其他一次性材料的成本。我们改良的方法简单、经济且准确,足以在资源有限的情况下监测抗逆转录病毒治疗。